News
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot ... HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need ...
The FDA on Wednesday approved a highly effective long-acting shot for HIV prevention that is administered just twice per year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results